Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial aims to clear painful hand and foot skin condition

NCT ID NCT07219420

Recruiting now Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational drug called bimekizumab can help control palmoplantar pustulosis, a chronic skin disease that causes painful pustules on the palms and soles. About 320 adults with moderate-to-severe symptoms will receive either the drug or a placebo for 16 weeks, followed by an open-label period where all participants can receive the drug. The main goal is to see if bimekizumab can clear or nearly clear skin lesions and improve quality of life compared to a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PALMOPLANTAR PUSTULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ppp001 20022

    RECRUITING

    Hangzhou, China

  • Ppp001 20136

    RECRUITING

    Tianjin, China

  • Ppp001 20137

    RECRUITING

    Chengdu, China

  • Ppp001 20184

    RECRUITING

    Shenzhen, China

  • Ppp001 20313

    RECRUITING

    Guangzhou, China

  • Ppp001 20345

    RECRUITING

    Shanghai, China

  • Ppp001 20350

    RECRUITING

    Chongqing, China

  • Ppp001 20352

    RECRUITING

    Chengdu, China

  • Ppp001 20355

    RECRUITING

    Jinan, China

  • Ppp001 20356

    RECRUITING

    Xi'an, China

  • Ppp001 20357

    RECRUITING

    Beijing, China

  • Ppp001 40249

    RECRUITING

    Kiel, Germany

  • Ppp001 40297

    RECRUITING

    Manises, Spain

  • Ppp001 40356

    RECRUITING

    Dresden, Germany

  • Ppp001 40396

    RECRUITING

    Rzeszów, Poland

  • Ppp001 40567

    RECRUITING

    Roma, Italy

  • Ppp001 40604

    RECRUITING

    Warsaw, Poland

  • Ppp001 40625

    RECRUITING

    Warsaw, Poland

  • Ppp001 40637

    RECRUITING

    Gdansk, Poland

  • Ppp001 40740

    RECRUITING

    Bad Bentheim, Germany

  • Ppp001 40743

    RECRUITING

    Szczecin, Poland

  • Ppp001 40750

    RECRUITING

    Alicante, Spain

  • Ppp001 40757

    RECRUITING

    Poznan, Poland

  • Ppp001 40816

    RECRUITING

    Brescia, Italy

  • Ppp001 40862

    RECRUITING

    Wroclaw, Poland

  • Ppp001 40866

    RECRUITING

    Göttingen, Germany

  • Ppp001 40875

    RECRUITING

    Ahaus, Germany

  • Ppp001 40880

    RECRUITING

    London, United Kingdom

  • Ppp001 40886

    RECRUITING

    Hellerup, Denmark

  • Ppp001 40888

    RECRUITING

    Madrid, Spain

  • Ppp001 40889

    RECRUITING

    Málaga, Spain

  • Ppp001 40893

    RECRUITING

    Bochum, Germany

  • Ppp001 40894

    RECRUITING

    Orosháza, Hungary

  • Ppp001 40895

    RECRUITING

    Debrecen, Hungary

  • Ppp001 40915

    RECRUITING

    Krakow, Poland

  • Ppp001 50233

    RECRUITING

    Barrie, Canada

  • Ppp001 50740

    RECRUITING

    Québec, Canada

  • Ppp001 50749

    RECRUITING

    Fredericton, Canada

  • Ppp001 50750

    RECRUITING

    Surrey, Canada

  • Ppp001 50752

    RECRUITING

    Red Deer, Canada

  • Ppp001 50765

    RECRUITING

    London, Canada

Conditions

Explore the condition pages connected to this study.

PALMOPLANTAR PUSTULOSIS